Eli Lilly's Foundayo gains FDA approval and hits market by April 6

Foundayo (orforglipron) received FDA approval on April 1 using the agency's new commissioner voucher program for expedited review. Insurance coverage costs $25/month; self-pay is $149. No meal restrictions required.